Cephalon Granted TRO In Amrix Patent MDL
The Delaware federal judge overseeing the multidistrict litigation over Cephalon Inc.'s Amrix drug granted a temporary restraining order Friday that would prevent Mylan Pharmaceuticals Inc. from launching generic versions of the...To view the full article, register now.
Already a subscriber? Click here to view full article